BackgroundPitavastatin is the newest statin available in Brazil and likely the one with
fewer side effects. Thus, pitavastatin was evaluated in hypercholesterolemic
rabbits in relation to its action on vascular reactivity.ObjectiveTo assess the lowest dose of pitavastatin necessary to reduce plasma lipids,
cholesterol and tissue lipid peroxidation, as well as endothelial function in
hypercholesterolemic rabbits.MethodsThirty rabbits divided into six groups (n = 5): G1 - standard chow diet; G2 -
hypercholesterolemic diet for 30 days; G3 - hypercholesterolemic diet and after
the 16th day, diet supplemented with pitavastatin (0.1 mg); G4 -
hypercholesterolemic diet supplemented with pitavastatin (0.25 mg); G5 -
hypercholesterolemic diet supplemented with pitavastatin (0.5 mg); G6 -
hypercholesterolemic diet supplemented with pitavastatin (1.0 mg). After 30 days,
total cholesterol, HDL, triglycerides, glucose, creatine kinase (CK), aspartate
aminotransferase (AST), alanine aminotransferase (ALT) were measured and LDL was
calculated. In-depth anesthesia was performed with sodium thiopental and aortic
segments were removed to study endothelial function, cholesterol and tissue lipid
peroxidation. The significance level for statistical tests was 5%.ResultsTotal cholesterol and LDL were significantly elevated in relation to G1. HDL was
significantly reduced in G4, G5 and G6 when compared to G2. Triglycerides, CK,
AST, ALT, cholesterol and tissue lipid peroxidation showed no statistical
difference between G2 and G3-G6. Significantly endothelial dysfunction reversion
was observed in G5 and G6 when compared to G2.ConclusionPitavastatin starting at a 0.5 mg dose was effective in reverting endothelial
dysfunction in hypercholesterolemic rabbits.